Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03136497
Brief Title: A Study of ABT-199 Plus Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

First Submitted : April 20, 2017
First Submitted that Met QC Criteria : April 27, 2017
First Posted : May 2, 2017

Last Update Submitted that Met QC Criteria : August 15, 2019
Last Update Posted : August 19, 2019